Chemotherapy of Hodgkin’s lymphoma with alternating cycles of COPP (cyclophosphamide, vincristin, procarbazine, prednisone) and ABVD (doxorubicin, bleomycin, vinblastine and dacarbazine). Results of the HD1 and HD3 trials of the German Hodgkin Study Group

Publication | Closed Access

DOI

Citations

References

1989

Year

Volker Diehl, Michael Pfreundschuh, Markus Löffler, U Rühl, Erhard Hiller, H Gerhartz, W. Wilmanns, Hartmut Kirchner, W. D. Schoppe, S. Petsch,

Medical Oncology and Tumor Pharmacotherapy

Lymphoid NeoplasiaHodgkin ’MedicineImmunologyPathologyCancer TreatmentOncologyChemotherapyCancer ResearchHd3 Trials